Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD3 Mono): A randomised, 52week, phase III, doubleblind, paralleltreatment trial
She is kind and attentive & very caring
The standard daily intake is 1-2 capsules per day, depending on individual needs, goals, and tolerance
The goal is always to identify what is actually driving the symptoms and prescribe accordingly, which is why the conversation starts with a consultation and labs rather than a product selection
Association of Glucagon-Like Peptide-1 Receptor Agonist Use With Risk of Gallbladder and Biliary Diseases: A Systematic Review and Meta-analysis
The research was supported by the Cancer Prevention and Research Institute of Texas (RP170114 and RP180778) and by the National Institutes of Health (NIH